CCMR
OGN icon

Core Capital Management & Research’s Organon & Co OGN Stock Holding History

Core Capital Management & Research’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179 Buy
+13
New +$155 ﹤0.01% 212

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Core Capital Management & Research's OGN Position: Q2 2026 in Review

Core Capital Management & Research opened a new position in Organon & Co (OGN) in Q2 2026: 13 shares worth $179. The stake represents ﹤0.01% of the portfolio and ranks #212 among its holdings.

636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Core Capital Management & Research held 13 shares of Organon & Co worth $179 as of Q2 2026.
  • Organon & Co was a new Core Capital Management & Research position in Q2 2026.
  • Organon & Co made up ﹤0.01% of Core Capital Management & Research's portfolio in Q2 2026, its #212 holding.
  • 636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Core Capital Management & Research's 13F filing for Q2 2026, filed 9 Sep 2026.